Treatment with recombinant alfa-2b-interferon in a patient with advanced B-CLL resulting in complete remission of skin lesions after one month therapy is reported in this paper. Interferon was administered subcutaneously three times weekly. Six months later while the treatment continued, the disease remained stable.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
skin lesion's
4
lesion's treatment
4
treatment alfa
4
alfa interferon
4
interferon patient
4
patient b-cll
4
b-cll treatment
4
treatment recombinant
4
recombinant alfa-2b-interferon
4
alfa-2b-interferon patient
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!